CIARDULLO STEFANO

Mantovani, A., Ciardullo, S., Sani, E., Csermely, A., Shtembari, E., Milani, I., et al. (2025). Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study. DIABETES & METABOLISM, 51(5 (September 2025)) [10.1016/j.diabet.2025.101684]. Dettaglio

Vergani, M., Borella, N., Rizzo, M., Conti, M., Perra, S., Bianconi, E., et al. (2025). Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study. DIABETES, OBESITY AND METABOLISM, 27(6), 3201-3211 [10.1111/dom.16333]. Dettaglio

Ciardullo, S., Perseghin, G. (2025). Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes. THE LANCET. GASTROENTEROLOGY & HEPATOLOGY, 10(2 (February 2025)), 97-98 [10.1016/s2468-1253(24)00325-x]. Dettaglio

Conti, M., Pontiggia, L., Vergani, M., Muraca, E., Cannistraci, R., Perra, S., et al. (2025). Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting. ACTA DIABETOLOGICA, 62(7), 1065-1072 [10.1007/s00592-024-02424-9]. Dettaglio

Rea, F., Muraca, E., Morabito, G., Oltolini, A., Bongo, A., Perseghin, G., et al. (2025). Medication Use Before and After Different Bariatric Surgery Procedures: Results from a Population-Based Cohort Study. OBESITY SURGERY, 35(6), 2240-2248 [10.1007/s11695-025-07911-8]. Dettaglio